Azad Institute of Pharmacy and Research (AIPR), situated in Lucknow, Uttar Pradesh, stands as a distinguished institution committed to excellence in pharmaceutical education. Established in 2005 as a key part of the reputable Azad Group of Educational Institutions, AIPR is affiliated with Dr. A.P.J. Abdul Kalam Technical University, Lucknow. It holds crucial approvals from the All India Council for Technical Education (AICTE) and the Pharmacy Council of India (PCI), ensuring compliance with national academic standards.
AIPR is acclaimed for its robust academic programs, specifically designed for the dynamic pharmaceutical sector. The institute offers a Bachelor of Pharmacy (B.Pharm), a Diploma in Pharmacy (D.Pharm), and specialized Master of Pharmacy (M.Pharm) degrees in Pharmaceutics and Pharmacology. These programs are expertly delivered across six dedicated departments: Pharmaceutics, Pharmaceutical Chemistry, Pharmacology, Pharmacognosy, Pharmaceutical Analysis, and Pharmacy Practice. This structured curriculum emphasizes both comprehensive theoretical knowledge and essential practical skills. With a total seat capacity of 190, AIPR admits students who qualify through competitive entrance examinations such as CUET for undergraduate admissions and GPAT for postgraduate courses.
The institution is dedicated to cultivating a supportive and enriching learning environment. Students benefit from modern pedagogical methods, hands-on laboratory training, and a curriculum continuously updated to meet industry demands. While specific campus area details for the pharmacy institute are integrated within the larger Azad Group campus, it provides a well-resourced academic setting. Graduates from Azad Institute of Pharmacy and Research are thoroughly prepared for diverse career opportunities in pharmaceutical manufacturing, research and development, quality control, marketing, and community pharmacy. AIPR consistently aims to produce highly competent and industry-ready pharmaceutical professionals, ready to contribute significantly to healthcare and pharmaceutical innovation.